SN
Senzime AB (publ)
SNZZF · OTC
$0.35 +0.00% (+$0.00)
1M -12.73%
Market Cap 525.8M kr
P/E Ratio -
Div. Yield -
ROE 37.22%
Piotroski F-Score Weak
3/9Valuation
61 /100
Fair P/B 1.99x
P/S 5.13x
P/FFO N/A
Growth
89 /100
Growing Book val. growth 5.06%
Rev. growth 94.81%
FCF growth N/A
Profitability
12 /100
Weak Net margin 108.94%
Op. margin 112.01%
FCF margin 94.21%
Quality
4 /100
Poor ROE 37.22%
ROA 34.31%
Asset turnover 0.31x
Debt
69 /100
Low Current ratio 3.31x
Int. coverage -24.49x
Debt/Equity 0.09x
Stability
43 /100
Moderate Rev. volatility 49.15%
EPS volatility 16.20%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNZZF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Philip Siberg
Employees
58
Headquarters
Uppsala
Upcoming events
29 OCT
Earnings
Upcoming earnings report